Xiaochun Yu Email & Phone Number

Duarte, California, United States

• Lead a research group with more than 12 research fellows, publish more than 30 manuscripts in cancer research, obtained three NIH R01 grants and many other foundation grants, give more than 30 invited presentations.• Identify PARG inhibitor, TET inhibitor, TARG1 inhibitor for cancer suppression.• Demonstrate that anti-oxidants are able to selective suppress familial breast, ovarian and pancreatic cancer.• Investigate cancer chemoresistant of FDA-approved PARP inhibitors

Ann Arbor, Michigan, United States

• Maintain a research laboratory with more than 8 research fellows, publish more than 20 manuscripts in cancer research, obtain four NIH R01 and many other foundation grants, give more than 20 invited presentations.• Study PARP inhibitors in cancer chemotherapy• Explore epigenetics in cancer development• Examine DNA damage repair defects in cancer development

Ann Arbor, Michigan, United States

• Start to manage a research laboratory, publish 18 manuscripts, obtained two NIH R01 grants.• Study the role of DNA damage repair in tumorigenesis• Explore posttranslational modifications in DNA damage repair pathways

Rochester, Minnesota, United States

• Publish 7 manuscripts, obtained two foundation grants and two postdoctoral fellowships• Examine mutations of BRCA1 and BRCA2 in hereditary breast and ovarian cancer• Study novel regulators in cell cycle checkpoints• Investigation novel regulators in mitosis

Kurume,Fukuoka

• Study signal transduction in ovarian cancer development and therapy

M.D., Medicine

Ph.D, Cell Biology